David Moore, Ph D - Publications

Affiliations: 
University of Manchester University of Manchester, Manchester, England, United Kingdom 
Area:
Coprinus Genetics & Biochemistry

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Seear K, Moore D, Fraser S, Fomiatti R, Aitken C. Consumption in contrast: The politics of comparison in healthcare practitioners' accounts of men who inject performance and image-enhancing drugs. The International Journal On Drug Policy. 85: 102883. PMID 32798925 DOI: 10.1016/J.Drugpo.2020.102883  0.315
2019 Moore D, Hart A, Fraser S, Seear K. Masculinities, practices and meanings: A critical analysis of recent literature on the use of performance- and image-enhancing drugs among men. Health (London, England : 1997). 1363459319838595. PMID 30922123 DOI: 10.1177/1363459319838595  0.307
2018 Marquine MJ, Flores I, Kamat R, Johnson N, Umlauf A, Letendre S, Jeste D, Grant I, Moore D, Heaton RK. A composite of multisystem injury and neurocognitive impairment in HIV infection: association with everyday functioning. Journal of Neurovirology. PMID 29777462 DOI: 10.1007/S13365-018-0643-3  0.301
2017 Krüsi A, McNeil R, Moore D, Small W. 'Because I've been extremely careful': HIV seroconversion, responsibility, citizenship and the neo-liberal drug-using subject. Health, Risk & Society. 19: 58-73. PMID 28989321 DOI: 10.1080/13698575.2016.1245850  0.303
2017 Abella Roth E, Cui Z, Rich A, Lachowsky N, Sereda P, Card K, Jollimore J, Howard T, Armstrong H, Moore D, Hogg R. Seroadaptive Strategies of Vancouver Gay and Bisexual Men in a Treatment as Prevention Environment. Journal of Homosexuality. PMID 28506154 DOI: 10.1080/00918369.2017.1324681  0.304
2015 Carter A, Lachowsky N, Rich A, Forrest JI, Sereda P, Cui Z, Roth E, Kaida A, Moore D, Montaner JS, Hogg RS. Gay and bisexual men's awareness and knowledge of treatment as prevention: findings from the Momentum Health Study in Vancouver, Canada. Journal of the International Aids Society. 18: 20039. PMID 26268817 DOI: 10.7448/Ias.18.1.20039  0.304
2015 Patterson S, Cescon A, Samji H, Cui Z, Yip B, Lepik KJ, Moore D, Lima VD, Nosyk B, Harrigan PR, Montaner JS, Shannon K, Wood E, Hogg RS. Cohort Profile: HAART Observational Medical Evaluation and Research (HOMER) cohort. International Journal of Epidemiology. 44: 58-67. PMID 24639444 DOI: 10.1093/Ije/Dyu046  0.317
2015 Duff C, Moore D. Evading and embracing normality: estrangement and ambivalence in the accounts of methamphetamine consumers Critical Public Health. 25: 488-503. DOI: 10.1080/09581596.2014.913785  0.311
2014 Ingle SM, May MT, Gill MJ, Mugavero MJ, Lewden C, Abgrall S, Fätkenheuer G, Reiss P, Saag MS, Manzardo C, Grabar S, Bruyand M, Moore D, Mocroft A, Sterling TR, et al. Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 59: 287-97. PMID 24771333 DOI: 10.1093/Cid/Ciu261  0.302
2014 Moore D. Editor’s Introduction A New and Exciting Era for Contemporary Drug Problems Contemporary Drug Problems. 41: 487-488. DOI: 10.1177/0091450914567121  0.327
2014 Seear K, Moore D. Complexity: Researching alcohol and other drugs in a multiple world Contemporary Drug Problems. 41: 295-300. DOI: 10.1177/009145091404100302  0.321
2013 Anema A, Marshall BD, Stevenson B, Gurm J, Montaner G, Small W, Roth EA, Lima VD, Montaner JS, Moore D, Hogg RS. Intergenerational sex as a risk factor for HIV among young men who have sex with men: a scoping review. Current Hiv/Aids Reports. 10: 398-407. PMID 24272070 DOI: 10.1007/S11904-013-0187-3  0.307
2013 Dwyer R, Moore D. Enacting multiple methamphetamines: the ontological politics of public discourse and consumer accounts of a drug and its effects. International Journal of Drug Policy. 24: 203-211. PMID 23540297 DOI: 10.1016/J.Drugpo.2013.03.003  0.312
2013 Karasaki M, Fraser S, Moore D, Dietze P. The place of volition in addiction: differing approaches and their implications for policy and service provision. Drug and Alcohol Review. 32: 195-204. PMID 22963577 DOI: 10.1111/J.1465-3362.2012.00501.X  0.303
2011 Michelow W, Hogg R, Moore D, Gustafson R, Trussler T, McGuire M, Gilbert M. P1-S2.60 Prevalence and correlates of giving or receiving sex for money, drugs or goods among men who have sex with men in Vancouver, British Columbia Sexually Transmitted Infections. 87. DOI: 10.1136/Sextrans-2011-050108.117  0.318
2009 Moore D, Dray A, Green R, Hudson SL, Jenkinson R, Siokou C, Perez P, Bammer G, Maher L, Dietze P. Extending drug ethno-epidemiology using agent-based modelling. Addiction (Abingdon, England). 104: 1991-7. PMID 19804460 DOI: 10.1111/J.1360-0443.2009.02709.X  0.304
2009 Green R, Moore D. ‘Kiddie drugs’ and controlled pleasure: Recreational use of dexamphetamine in a social network of young Australians International Journal of Drug Policy. 20: 402-408. PMID 19168342 DOI: 10.1016/J.Drugpo.2008.12.002  0.301
2007 Kerr T, Small W, Moore D, Wood E. A micro-environmental intervention to reduce the harms associated with drug-related overdose: Evidence from the evaluation of Vancouver's safer injection facility International Journal of Drug Policy. 18: 37-45. PMID 17689342 DOI: 10.1016/J.Drugpo.2006.12.008  0.31
2006 Connock M, Burls A, Frew E, Fry-Smith A, Juarez-Garcia A, McCabe C, Wailoo A, Abrams K, Cooper N, Sutton A, O'Hagan A, Moore D. The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review. Health Technology Assessment (Winchester, England). 10: iii-iv, ix-136. PMID 16796930 DOI: 10.3310/Hta10240  0.301
2006 Miller P, Moore D, Strang J. The regulation of research by funding bodies: An emerging ethical issue for the alcohol and other drug sector? International Journal of Drug Policy. 17: 12-16. DOI: 10.1016/J.Drugpo.2005.10.002  0.301
2005 Moore D, Montaner J. Total lymphocyte counts and ART in resource-limited settings The Lancet. 366: 1831-1832. PMID 16310537 DOI: 10.1016/S0140-6736(05)67736-7  0.306
2005 Moore D, Dietze PM. Enabling environments and the reduction of drug-related harm: re-framing Australian policy and practice. Drug and Alcohol Review. 24: 275-284. PMID 16096131 DOI: 10.1080/09595230500170258  0.302
2004 Moore D. Governing street-based injecting drug users: a critique of heroin overdose prevention in Australia. Social Science & Medicine. 59: 1547-1557. PMID 15246182 DOI: 10.1016/J.Socscimed.2004.01.029  0.312
2002 Moore D. Opening up the Cul-de-Sac of Youth Drug Studies: A Contribution to the Construction of Some Alternative Truths: Contemporary Drug Problems. 29: 13-63. DOI: 10.1177/009145090202900103  0.31
1988 Loftus MG, Moore D, Elliott TJ. DNA polymorphisms in commercial and wild strains of the cultivated mushroom, Agaricus bisporus. Tag. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik. 76: 712-8. PMID 24232349 DOI: 10.1007/BF00303517  0.407
Show low-probability matches.